Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or OpenAthens)

For the academic login, please select your organization on the next page. You will be redirected to verify your credentials.

OpenAthens/Shibboleth

Editorial

Open Access Gateway

Bacterial Infections in Patients with Cirrhosis Admitted to the Hospital

Sousa Cardoso F.

Author affiliations

Intensive Care Unit, Curry Cabral Hospital, Central Lisbon Hospital Center, Nova University, Lisbon, Portugal

Corresponding Author

Filipe Sousa Cardoso

Intensive Care Unit, Curry Cabral Hospital

Central Lisbon Hospital Center, Nova University

Rua da Beneficiência N8, PT–1066-069 Lisbon (Portugal)

E-Mail filipe_sousacardoso@hotmail.com

Related Articles for ""

GE Port J Gastroenterol 2019;26:312–313

Do you have an account?

Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.




First-Page Preview
Abstract of Editorial

Infecções bacterianas em doentes com cirrose admitidos no hospital

Palavras Chave

Peritonite · Sépsis · Fígado ·




Related Articles:


References

  1. Fernández J, Acevedo J, Castro M, Garcia O, de Lope CR, Roca D, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology. 2012 May;55(5):1551–61.
  2. Moreau R, Jalan R, Ginès P, Pavesi M, Angeli P, Cordoba J, et al.; CANONIC Study Investigators of the EASL–CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013 Jun;144(7):1426–37.
  3. Gomes CL, Silva RV, Carrola P, Presa J. Bacterial infections in patients with liver cirrhosis in an internal medicine department. GE Port J Gastroenterol. 2018, DOI: 10.1159/000494568.
    External Resources
  4. Oliveira AM, Branco JC, Barosa R, Rodrigues JA, Ramos L, Martins A, et al. Clinical and microbiological characteristics associated with mortality in spontaneous bacterial peritonitis: a multicenter cohort study. Eur J Gastroenterol Hepatol. 2016 Oct;28(10):1216–22.
  5. Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014 Jun;60(6):1310–24.

Article / Publication Details

Received: November 12, 2018
Accepted: November 22, 2018
Published online: January 11, 2019
Issue release date: September - October

Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 0

ISSN: 2341-4545 (Print)
eISSN: 2387-1954 (Online)

For additional information: https://www.karger.com/PJG

References

  1. Fernández J, Acevedo J, Castro M, Garcia O, de Lope CR, Roca D, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology. 2012 May;55(5):1551–61.
  2. Moreau R, Jalan R, Ginès P, Pavesi M, Angeli P, Cordoba J, et al.; CANONIC Study Investigators of the EASL–CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013 Jun;144(7):1426–37.
  3. Gomes CL, Silva RV, Carrola P, Presa J. Bacterial infections in patients with liver cirrhosis in an internal medicine department. GE Port J Gastroenterol. 2018, DOI: 10.1159/000494568.
    External Resources
  4. Oliveira AM, Branco JC, Barosa R, Rodrigues JA, Ramos L, Martins A, et al. Clinical and microbiological characteristics associated with mortality in spontaneous bacterial peritonitis: a multicenter cohort study. Eur J Gastroenterol Hepatol. 2016 Oct;28(10):1216–22.
  5. Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014 Jun;60(6):1310–24.

Open Access License / Drug Dosage / Disclaimer

This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.